A symptom complex that includes early satiety, bloating, abdominal and/or pelvic pain, and urinary changes frequently precedes a diagnosis of ovarian cancer.
A symptom complex that includes early satiety, bloating, abdominal and/or pelvic pain, and urinary changes frequently precedes a diagnosis of ovarian cancer. The bad news is that awareness of these symptoms is not yet translating into earlier diagnosis or increased overall survival, according to the findings of a recent retrospective case-control study at the Fred Hutchinson Cancer Center in Seattle, Washington.
Researchers calculated that such symptoms are about 10 times more common in women ultimately diagnosed with the disease.
The symptoms were present whether the women had early- or late-stage cancer, whether they had invasive or borderline tumors, and whether they had type I or II tumors.
In the end, however, the authors calculated that using symptoms to trigger a workup for ovarian cancer would likely result in only 1 more diagnosis in 100 women.
Cass T, Karlan BY. Ovarian cancer symptoms speak out-but what are they really saying? J Natl Cancer Inst. 2010;102(4):211-212.
Rossing MA, Wicklund KG, Cushing-Haugen KL, Weiss NS. Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer lnst. 2010;102(4):222-229.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More